6-6172447-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000129.4(F13A1):​c.1747+2133A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.655 in 150,182 control chromosomes in the GnomAD database, including 33,188 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.65 ( 33188 hom., cov: 28)

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.882

Publications

2 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
NM_000129.4
MANE Select
c.1747+2133A>G
intron
N/ANP_000120.2P00488

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
ENST00000264870.8
TSL:1 MANE Select
c.1747+2133A>G
intron
N/AENSP00000264870.3P00488
F13A1
ENST00000950947.1
c.1747+2133A>G
intron
N/AENSP00000621006.1
F13A1
ENST00000878383.1
c.1558+2133A>G
intron
N/AENSP00000548442.1

Frequencies

GnomAD3 genomes
AF:
0.655
AC:
98234
AN:
150080
Hom.:
33141
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.816
Gnomad AMI
AF:
0.586
Gnomad AMR
AF:
0.511
Gnomad ASJ
AF:
0.659
Gnomad EAS
AF:
0.600
Gnomad SAS
AF:
0.707
Gnomad FIN
AF:
0.666
Gnomad MID
AF:
0.777
Gnomad NFE
AF:
0.588
Gnomad OTH
AF:
0.665
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.655
AC:
98324
AN:
150182
Hom.:
33188
Cov.:
28
AF XY:
0.658
AC XY:
48152
AN XY:
73224
show subpopulations
African (AFR)
AF:
0.816
AC:
33311
AN:
40820
American (AMR)
AF:
0.510
AC:
7727
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
0.659
AC:
2283
AN:
3462
East Asian (EAS)
AF:
0.601
AC:
3041
AN:
5064
South Asian (SAS)
AF:
0.709
AC:
3374
AN:
4758
European-Finnish (FIN)
AF:
0.666
AC:
6726
AN:
10106
Middle Eastern (MID)
AF:
0.781
AC:
228
AN:
292
European-Non Finnish (NFE)
AF:
0.588
AC:
39719
AN:
67532
Other (OTH)
AF:
0.665
AC:
1384
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1551
3102
4652
6203
7754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.602
Hom.:
101401
Bravo
AF:
0.646
Asia WGS
AF:
0.664
AC:
2268
AN:
3414

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.1
DANN
Benign
0.49
PhyloP100
0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387528; hg19: chr6-6172680; API